CN1289610A

CN1289610A - Chinese patent medicine (Tangshenkang) for treating diabetes and nephrosis and its preparing process

Info

Publication number: CN1289610A
Application number: CN 00129560
Authority: CN
Inventors: 裘松雅; 裘晓富
Original assignee: Individual
Current assignee: Individual
Priority date: 2000-10-08
Filing date: 2000-10-08
Publication date: 2001-04-04
Anticipated expiration: 2020-10-08
Also published as: CN1124851C

Abstract

A Chinese patent medicine in the form of capsule or pill for treating diabetes and nephrosis is prepared from 8 Chinese-medicinal materials including astraglus root, white atractylodes rhizome, rhubarb, prepared rehmannia root, etc. Its advantages include high curative effect and no by-effect.

Description

Chinese patent medicine--Tangshenkang and preparation method thereof of treatment diabetic nephropathy

The present invention relates to a kind of Chinese patent medicine goods and preparation method thereof, especially a kind of Chinese patent medicine for the treatment of the diabetic complication nephropathy and preparation method thereof.

Diabetic nephropathy is the complication that is caused by diabetes, is having a strong impact on the healthy of people, and even life.At present, the Chinese patent drug that is generally used for treating diabetic nephropathy mainly contains shenyankangfu tablet, SHENFUKANG JIAONANG, LIUWEI DIHUANG WAN etc., but medicines of these treatment nephropathy for treatment by diabetes complicated low, the weak effect of nephropathy curative effect.Then adopt the treatment means of hemodialysis, renal transplantation to save patient's life to the diabetic nephropathy patient that develops into late period, but the medical expense costliness, survival rate is lower.Thereby, be badly in need of the effectively novel drugs of treatment diabetic nephropathy of development.

The purpose of this invention is to provide a kind of Chinese patent drug for the treatment of diabetic nephropathy and preparation method thereof, make its can treating both the principal and secondary aspects of a disease, curative effect is reliable, effect is obvious, has no side effect, reach to treat diabetic nephropathy effectively.

For achieving the above object, the technical solution used in the present invention is: according to China's Chinese medical theory, in conjunction with the achievement of clinical treatment experimental study for many years, selected employing is a raw material by the pure Chinese medicinal herbs of this 8 flavor of the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Radix Et Rhizoma Rhei, Radix Rehmanniae Preparata, Fructus Corni, Fructus Schisandrae Chinensis, Fructus Rosae Laevigatae and Radix Paeoniae Rubra, and be by weight ratio: Radix Astragali 20-40, Rhizoma Atractylodis Macrocephalae 15-25, Radix Et Rhizoma Rhei 5-15, Radix Rehmanniae Preparata 25-40, Fructus Corni 5-15, Fructus Schisandrae Chinensis 15-25, Fructus Rosae Laevigatae 5-15, Radix Paeoniae Rubra 15-25 prescription are made the Chinese patent drug of capsule or pill.

The present invention treats the Chinese patent medicine of diabetic nephropathy--and the manufacture method of Tangshenkang is:

By above-mentioned prescription 8 flavor Chinese medicinal herbses are equipped with respectively by weight, cleaning is dried; Earlier the Radix Astragali, Radix Rehmanniae Preparata, Fructus Schisandrae Chinensis, Fructus Rosae Laevigatae, this 5 flavor medical material of Radix Paeoniae Rubra are closed altogether and extract active ingredient and concentrate and make, carry out cold drying; Simultaneously with the medicated powder of this 3 flavor pulverizing medicinal materials of remaining Fructus Corni, the Rhizoma Atractylodis Macrocephalae and Radix Et Rhizoma Rhei after sieving, lump together with the extraction concentrate drying agent of above-mentioned 5 flavor medicines and to stir, through circulating baking oven sterilization, make granule again; Dress up capsule by every 0.3-1.0 gram, pack at last and check, promptly become Tangshenkang capsule of the present invention.The medicated powder that maybe will extract concentrate drying agent and crushing screening unified stir after, first molding, the screening single-size is made ball, again after circulating baking oven sterilization, coating, dries, and packs at last and checks, and is made for Tangshenkang pill product of the present invention.Certainly, also may be made in powder, tablet or other dosage form.The oral each 1.5-3 gram of adult's usual amounts, every day 3 times, or follow the doctor's advice.

Treatment diabetic nephropathy Chinese patent medicine of the present invention is the theory that utilization differential diagnosis in tcm opinion is controlled, etiology and pathogenesis in conjunction with the glycosuria nephropathy, at the diabetic nephropathy main diseases because of being to cause the renal function imbalance by diabetes development, influenced the microcirculation of kidney, cause the interior poisonous substance of body to get rid of not smooth, so that cause blood urea nitrogen, serum creatinine, urinaryalbumin, urine α 1-microglobulin etc. to increase, thereby by diabetes complicated diabetic nephropathy.According to the principle of suiting the remedy to the case, pathological study and tcm clinical practice practice in conjunction with diabetic nephropathy, through experimental study for many years, the pure Chinese medicinal herbs compound compatibility of this 8 flavor of the selected Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Radix Et Rhizoma Rhei, Radix Rehmanniae Preparata, Fructus Corni, Fructus Schisandrae Chinensis, Fructus Rosae Laevigatae and Radix Paeoniae Rubra is made Chinese patent medicine--the Tangshenkang of treatment diabetic nephropathy.Its pharmacology is: the Radix Astragali has kidney and spleen invigorating, improve body immunity, improve effect such as renal function, can make the kidney cell reparation, and diuresis is arranged, and can be got rid of toxicants such as blood urea nitrogen simultaneously by the diuresis increase, and Radix Astragali diuresis is gentle lastingly.Radix Rehmanniae Preparata, Radix Paeoniae Rubra have the yin fluid astringing of nourishing blood effect.Radix Et Rhizoma Rhei has the renal function of improvement, reduces urinaryalbumin row and rushes down, suppresses effects such as synthesizing of blood urea nitrogen, and can increase the drainage of poisonous substances such as the interior blood urea nitrogen of enteric cavity.The Rhizoma Atractylodis Macrocephalae, Fructus Corni, Fructus Schisandrae Chinensis, Fructus Rosae Laevigatae have effects such as the kidney invigorating diuresis.Become Chinese patent drug with above-mentioned 8 herbal medicine prescription compatibilities are refining, have comprehensive effect such as kidney and spleen invigorating, benefiting QI for activating blood circulation, damp eliminating detumescence, diuresis is arranged again, reduce blood urea nitrogen, serum creatinine, urinaryalbumin, improve pharmacological actions such as renal function.

The present invention also can be again on the basis of above-mentioned main formula, by respectively the distinguish the flavor of weight proportion of Chinese medicinal herbs of main formula, adds Chinese medicinal herbs RHIIZOMA DIOSCOREAE frOm Henan of China 15-25, Radix Paeoniae Alba 15-25 and Poria 5-15 again, and the prescription compatibility is made Chinese patent medicine--Tangshenkang.

Because the present invention is the Chinese medical theory according to Chinese elite, in conjunction with cause of disease pharmacological research, through for many years, clinical practice, selected main formula is by the pure Chinese medicinal herbs of this 8 flavor of the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Radix Et Rhizoma Rhei, Radix Rehmanniae Preparata, Fructus Corni, Fructus Schisandrae Chinensis, Fructus Rosae Laevigatae and Radix Paeoniae Rubra, and can be again with addition of other flavor Chinese crude drug RHIIZOMA DIOSCOREAE frOm Henan of China, the Radix Paeoniae Alba and the made Chinese patent drug of Poria.It has comprehensive effect such as kidney and spleen invigorating, benefiting QI for activating blood circulation, damp eliminating detumescence, and this medicine mainly is applicable to the nephropathy that treatment is diabetes complicated, also can be used for the treatment of other nephropathy.Through 220 routine diabetic nephropathy patient clinical efficacy result of the tests are shown that total effective rate reaches 86.8%.The present invention has reliable drug effect basis, its processing technology uniqueness, and this medical instrument has advantages such as the flavour of a drug compatibility is reasonable, energy treating both the principal and secondary aspects of a disease, curative effect is reliable, effect is obvious, have no side effect, and is a kind of new Chinese patent medicine for the treatment of diabetic nephropathy.

Below in conjunction with drawings and Examples the present invention is described in further detail.

Fig. 1 is an embodiment of the invention Tangshenkang capsule processing technology flow chart.

In the accompanying drawing 11,2 ... 10 is manufacturing process.

The embodiment of the invention:

Medical material title prescription 1 prescription 2 prescriptions 3

The Radix Astragali 26 30 25

The Rhizoma Atractylodis Macrocephalae 18 22 20

Radix Et Rhizoma Rhei 12 15 13

Radix Rehmanniae Preparata 28 34 30

Fructus Corni 10 12 8

Fructus Schisandrae Chinensis 20 22 18

Fructus Rosae Laevigatae 12 13 14

Radix Paeoniae Rubra 18 22 20

RHIIZOMA DIOSCOREAE frOm Henan of China 16

The Radix Paeoniae Alba 22

Poria 10

With reference to accompanying drawing l embodiment, the capsular manufacture method of Tangshenkang of the present invention is: the pharmaceutical quantities by above-mentioned prescription 1 is equipped with each flavor medicine through weighing (1), respectively each flavor medical material is cleaned with 10-20 ℃ of warm water and dries (2); After Heshui extracts concentrated (3) altogether with the Radix Astragali, Radix Rehmanniae Preparata, Fructus Schisandrae Chinensis, Fructus Rosae Laevigatae, this 5 flavor medical material of Radix Paeoniae Rubra, carry out drying at 30-40 cryostat (4); Simultaneously with this 3 flavor medical material of remaining Fructus Corni, the Rhizoma Atractylodis Macrocephalae and Radix Et Rhizoma Rhei after pulverizing and crossing 100 mesh sieves (5), lump together stir (6) with the water extraction concentrate drying agent of above-mentioned 5 flavor medicines, through circulating baking oven sterilization (7), make granule (8) again; Dress up capsule (9) by every 0.3 gram and pack and check (10) again, promptly be made for Tangshenkang capsule pharmaceutical of the present invention.

Press manufacture method shown in the accompanying drawing 1, or behind agitating procedure (6), work being molded as ball earlier, after again through circulating drying baker sterilization, carrying out coating, drying, pack at last and check.Be made for Tangshenkang pill product of the present invention.

The clinical treatment model case:

Example 1: the virtue of opening, man, 62 years old, Yanshan County, the Hebei province cadre of Bureau of Education.Suffered from diabetes 21 years.Examine the time: on JIUYUE 6th, 1998.The situation of being admitted to hospital: puffiness of face, two lower limb severe pitting edemas, appetite is poor.Admission examination: blood pressure 180/llOmmHg, blood glucose 12.7mmoI/L, glucose in urine Urine protein , serum creatinine 286umol/L, blood urea nitrogen 8.9mmol/L, urine microglobulin 32mg/L.

Diagnosis: diabetic nephropathy

Dispose: advise the Tangshenkang capsule of taking prescription 1 of the present invention, each 6 (meter 1.8 grams), every day 3 times.

On JIUYUE 21st, 1998, take medicine after 2 weeks, and sb.'s illness took a favorable turn, and facial edema, two lower limbs edema disappear gradually, and appetite increases, and clinical symptoms is clearly better.

On October 6th, 1998, the check in 1 month of taking medicine, every biochemical indicator detects all more preceding improvement, blood glucose 70mmoI/L, glucose in urine (-), urine protein (+), serum creatinine 102UMOU/L, blood urea nitrogen 6.4mmoI/L.Advise and continue according to before taking this medicine.

On November 6th, 1998, checked after taking medicine again 1 month that every biochemical indicator is all reduced to normal range, clinical symptoms disappears entirely, advises to subtract this medicine of clothes each 3,2 times on the one, takes and consolidates curative effect in 1 month.

Example 2: Zhang Jinfu, woman, 32 years old, the Hui ethnic group, the Cangzhou City people of Hebei province.Examine the time: on October 17th, 1996.Patient suffered from diabetes 8 years, because of the diabetes menstrual cycle undesired, 6 years after marriage unpregnancies always.Human health screening: blood glucose 13.2MMOI/L, glucose in urine

Urine protein .Advise and take each 6 of Tangshenkang ball of the present invention (meter 1-8 gram), three times on the one. treat after 2 months, blood sugar recovery is normal, and urine protein reduces gradually.Treatment to 4 month patient's pregnancy.Continue to take the treatment of this medicine, mature life one girl baby of patient (2.85 kilograms of body weight) divides the puerperium patient to take the treatment of this medicine to 18 months always, and urine protein disappears, and reaches clinical cure.Follow up a case by regular visits to after 2 years, the mother and daughter is all healthy, and every biochemical indicator check is normal.

Claims

1, a kind of Chinese patent medicine for the treatment of diabetic nephropathy, it is characterized in that by the Chinese medicinal herbs Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Radix Et Rhizoma Rhei, Radix Rehmanniae Preparata, Fructus Corni, Fructus Schisandrae Chinensis, Fructus Rosae Laevigatae, Radix Paeoniae Rubra be pharmaceutical raw material, be by weight ratio: the Chinese patent medicine that Radix Astragali 20-40, Rhizoma Atractylodis Macrocephalae 15-25, Radix Et Rhizoma Rhei 5-15, Radix Rehmanniae Preparata 25-40, Fructus Corni 5-15, Fructus Schisandrae Chinensis 15-25, Fructus Rosae Laevigatae 5-15, Radix Paeoniae Rubra 15-25 prescription are made.

2, the Chinese patent medicine of treatment diabetic nephropathy according to claim 1 is characterized in that the manufacture method of this medicine is: earlier 8 flavor Chinese medicinal herbses are prepared by the weighing of proportioning difference, cleaning is dried; With this 5 flavor medical material of the Radix Astragali, Radix Rehmanniae Preparata, Fructus Schisandrae Chinensis, Fructus Rosae Laevigatae, Radix Paeoniae Rubra close altogether extract concentrate after, 30-40 ℃ of cold drying, after simultaneously this 3 flavor pulverizing medicinal materials of remaining Fructus Corni, the Rhizoma Atractylodis Macrocephalae and Radix Et Rhizoma Rhei being screened into medicated powder, unified and stirred with the extraction concentrate drying agent of above-mentioned 5 flavor medicines, through circulating baking oven sterilization, make granule again, dress up capsule by every 0.3 gram-1.0 grams, pack at last and check, promptly become Tangshenkang capsule pharmaceutical of the present invention.

3, the manufacture method of treatment diabetic nephropathy Chinese patent medicine according to claim 2, after the medicated powder that it is characterized in that maybe will extracting concentrate drying agent and pulverizing stirs, rise earlier and be molded as ball, again after circulating baking oven sterilization, carry out coating, dry, pack at last and check, become Tangshenkang pill product of the present invention.

4, the Chinese patent medicine of treatment diabetic nephropathy according to claim 1 is characterized in that pharmaceutical raw material adds RHIIZOMA DIOSCOREAE frOm Henan of China 15-25, Radix Paeoniae Alba 15-25 by weight ratio again and Poria 5-15 prescription is made Chinese patent medicine.